Edition:
United States

Erytech Pharma SA (ERYP.PA)

ERYP.PA on Paris Stock Exchange

6.57EUR
11:35am EST
Change (% chg)

€-0.03 (-0.38%)
Prev Close
€6.60
Open
€6.69
Day's High
€6.69
Day's Low
€6.40
Volume
30,044
Avg. Vol
46,791
52-wk High
€19.57
52-wk Low
€5.92

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 6 4.85 11.00 0.00 6.80
Year Ending Dec-19 6 5.45 13.00 0.00 10.87
Earnings (per share)
Year Ending Dec-18 5 -2.64 -2.25 -3.19 -1.90
Year Ending Dec-19 5 -3.21 -2.35 -3.54 -2.42
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 34.39
P/E High - Last 5 Yrs. -- 148.17 46.24
P/E Low - Last 5 Yrs. -- 47.84 24.59
Beta 0.86 1.08 0.91
Price to Sales (TTM) 80.61 49.58 6.22
Price to Book (MRQ) -- 10.17 5.20
Price to Tangible Book (MRQ) -- 13.83 6.74
Price to Cash Flow (TTM) -- 52.85 24.17
% Owned Institutions -- 3.75 1.78

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.94
Payout Ratio(TTM) -- 7.05 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -25.59 130.06 8.17
Sales (TTM) vs TTM 1 Yr. Ago -8.67 47.89 6.50
Sales - 5 Yr. Growth Rate 35.25 22.79 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago -37.52 75.90 23.08
EPS (TTM) vs TTM 1 Yr. Ago -27.13 -- --
EPS - 5 Yr. Growth Rate -- 12.04 10.49
Capital Spending - 5 Yr. Growth Rate 81.34 9.25 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.28
Current Ratio (MRQ) -- 3.44 3.10
LT Debt to Equity (MRQ) -- 18.69 11.49
Total Debt to Equity (MRQ) -- 31.36 16.03
Interest Coverage (TTM) -- -43.32 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.37 54.44
Gross Margin - 5 Yr. Avg. -- 60.62 52.36
EBITD Margin (TTM) -732.50 -- --
EBITD - 5 Yr. Avg -321.23 -109.98 13.16
Operating Margin (TTM) -736.87 -185.00 6.07
Operating Margin - 5 Yr. Avg. -331.17 -126.42 8.47
Pre-Tax Margin (TTM) -727.19 -175.77 7.02
Pre-Tax Margin - 5 Yr. Avg. -337.58 -132.58 8.71
Net Profit Margin (TTM) -727.87 -182.51 3.12
Net Profit Margin - 5 Yr. Avg. -337.31 -136.98 4.91
Effective Tax Rate (TTM) -- 21.47 23.26
Effective Tax Rate - 5 Yr. Avg. -- 15.43 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) 41,447 7,649,006 873,053,182
Net Income/Employee (TTM) -301,682 653,334 103,483,965
Receivable Turnover (TTM) -- 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.56
Asset Turnover (TTM) -- 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 6.47 11.45
Return on Assets - 5 Yr. Avg. -38.25 5.54 12.50
Return on Investment (TTM) -- 9.01 14.96
Return on Investment - 5 Yr. Avg. -46.07 6.87 16.23
Return on Equity (TTM) -- 10.15 16.52
Return on Equity - 5 Yr. Avg. -51.29 8.41 17.37
  1 Year 3 Year 5 Year
Sales % 41.28 31.92 35.25
EPS (TTM) % -27.20 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Erytech Pharma SA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -8.30 -12.52 36 98
13 Week -7.07 -10.79 72 94
26 Week -12.20 -15.88 76 98
52 Week 35.52 13.27 99 68
YTD 76.06 59.71 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 49.55%
# of Holders: 20
Total Shares Held: 8,887,149
3 Mo. Net Change: -1,048,482
# New Positions: 1
# Closed Positions: 7
# Increased Positions: 4
# Reduced Positions: 7
# Net Buyers: -3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.